Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

NCT07224581 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

GRIN-related Neurodevelopmental Disorder

Interventions

DRUG: Radiprodil
DRUG: Placebo

Sponsor

GRIN Therapeutics, Inc.

Collaborators

[object Object]